
DermaSensor Secures $16M to Scale AI-Powered Skin Cancer Detection in Primary Care
DermaSensor Inc. announced it has raised $16 million in Series B funding to fuel the commercial expansion of its FDA cleared, skin cancer detection solution. MIAMI, FL, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- DermaSensor Inc., a medical …